Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07390045 · ClinicalTrials.gov registry record · NA

Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors

A NA study, sponsored by University of Rochester.

Recruiting
Registry status
NA
Development phase
40
Enrollment target

NCT07390045: Recruiting NA study, sponsored by University of Rochester.

NCT07390045 is a NA study that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07390045, a NA study, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The objective of this study is to assess the preliminary effects of an integrated exercise and cognitive rehabilitation intervention (ECO), an exercise intervention (EXCAP), and a cognitive rehabilitation intervention (MAAT) as compared to usual care on objective cognition (Trail Making Test).

Primary Outcome

Trail Making Test A \& B: The Trail Making Test assesses sustained attention. The Written Trail Making Test A \& B is preferred; however, if this is not feasible, the oral Trail Making Test will be utilized. There is not a range, lower scores indicating better performance

Interventions

  • BEHAVIORAL EXCAP
  • BEHAVIORAL MAAT
  • BEHAVIORAL ECO

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-07-31
Est. Completion 2028-03-31
Phase NA
University of Rochester

636 total trials

What NCT07390045 shows while recruiting

NCT07390045 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 3 interventions - of which EXCAP is the first listed.

NCT07390045 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07390045 about?

NCT07390045 is a clinical study titled "Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors". The objective of this study is to assess the preliminary effects of an integrated exercise and cognitive rehabilitation intervention (ECO), an exercise intervention (EXCAP), and a cognitive rehabilitation intervention (MAAT) as compared to usual care on objective cognition (Trail Making Test).

What is the current status of trial NCT07390045?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-07-31. Estimated completion is 2028-03-31.

What interventions are being tested in trial NCT07390045?

The interventions under investigation include: EXCAP (BEHAVIORAL), MAAT (BEHAVIORAL), ECO (BEHAVIORAL).

Who is sponsoring clinical trial NCT07390045?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07390045's enrollment target sits among peer trials

40 1447th of 2000 higher than 465 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07390045, the US trial registry maintained by the National Library of Medicine. NCT07390045 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.